Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings outcomes in the present day.
Complete income decreased 3% year-over-year to $2.46 billion. Revenues had been down 3% on a continuing foreign money foundation as effectively.
Web earnings attributable to Biogen Inc. was $388.5 million, or $2.66 per share, in comparison with a lack of $68.1 million, or $0.47 per share, final 12 months. Adjusted EPS decreased 6% to $4.08.
For the total 12 months of 2024, Biogen expects complete income to say no by a low-single-digit proportion in comparison with the earlier 12 months. Adjusted EPS is predicted to be $16.10-16.60.
Prior efficiency
